Archives: Agenda

In the rapidly evolving landscape of procurement, staying ahead of the curve is more critical than ever.

This session will explore the transformative role of Artificial Intelligence (AI) in revolutionizing clinical business operations. Attendees will gain insights into how AI is reshaping strategic sourcing, vendor management, and cost optimization, enabling organizations to achieve unprecedented levels of efficiency and agility.

Through real-world use cases we’ll delve into AI-driven tools that enhance decision-making, streamline workflows, and predict study cost with unparalleled accuracy. Whether you’re an outsourcing manager, a clinical operations or R&D finance professional, this session will equip you with the knowledge and strategies needed to harness the power of AI for smarter, more effective procurement leveraging Clinical Maestro powerful engine.

• Discussing how AI is being applied across the trial lifecycle
• Looking at use cases from patient recruitment and site management to patient engagement and  retention
• Bridging both academic research and practical implementation

For clinical trials leaders and managers, Smartsheet is the Intelligent Work Management platform that optimizes clinical trial processes by reducing administrative burden, breaking down communication silos, and centralizing fragmented information. This talk will focus on key challenges from industry, outcomes that Smartsheet facilitates, capabilities and stories from existing customers

What is Patient Experience Data (PED)?

With a focus on clinical trials, and a data management perspective, Ane will cover study design considerations, patient burden, missing data and other challenges

This interactive session will delve into the challenges and opportunities in creating good sponsor CRO partnerships, with a focus on building stronger stakeholder relationships, enhancing transparency, and managing teams effectively through shared values, objectives and KPI’s

In the complex world of clinical research, even meticulously planned trials can face unexpected hurdles that threaten to derail progress and encounter obstacles beyond the capabilities of a small-scale Clinical Research Organization (CRO). When studies falter, a well-executed rescue strategy with an experienced global CRO becomes crucial. Drawing from Parexel’s extensive rescue-trial experience, this presentation unveils the blueprint for successful clinical trial transitions, focusing on four key phases:

• Strategic Initiation & Planning – establishing a robust framework and standardized processes
• Comprehensive Preparation & Due Diligence – ensuring stakeholder alignment on transition plans and timelines – Conducting thorough documentation review and gap analysis
• Adaptive Execution & Transfer – How to operationalize a study transfer – Anticipating challenges and employing agile governance for real-time course corrections
• Effective Closure & Delivery – defining clear transition thresholds and success metrics  – Ensuring continuity and maintaining data integrity throughout the process

• Examples from integrating DHTs, such as wearable devices, into clinical trials
• Device burden and patient-related factors
• Challenges faced by sites during DHT implementation

Discussing the status quo of clinical trials in Denmark and beyond including factors influencing country selection

• Considering barriers of success for site-set up and patient recruitment/screening
• Considering types of data that can be utilized to assist with patient recruitment challenges
• Incorporating data findings into development of eligibility criteria
• Using secondary health data to identify sites and patient cohorts